logo
Sign in

RTGN Stock Price, Chart, Stats & News

RetinalGenix Technologies Inc.
Save

RetinalGenix Technologies Inc. (RTGN) does not currently pay a dividend.

75.37M
Market cap
–
Current P/E
–
Forward P/E

RTGN chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Medical - Devices
Industry

RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients.

Similar securities

Based on sector and market capitalization

Report issue